MRIdian — the only choice for dose escalation in moving targets
MRIdian® - the world’s first
MRI-guided radiation therapy system to image and treat cancer patients simultaneously.
Please, contact us for more information
True image guided adaptive radiation therapy
The MRIdian® system gives clinicians a fresh approach to observing, assessing, and personalizing a patient’s treatment. The MRIdian system provides high-quality pretreatment images and continuous soft-tissue imaging during treatment while the beam is on.
Regulatory status:
Europe: BOTH the cobalt version of the MRIdian system and the new MR-Linac are CE marked and available. This is the first MRI-Linac available for purchase and clinical use in Europe.
USA: Both the previous cobalt version and the MR-Linac version of MRIdian are FDA cleared and in clinical use.
You can also visit the American ViewRay corporate website: www.viewray.com